Zeus Capital Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview to discuss City of London Investment Group PLC (LON:CLIG) Q1: Now..
Diurnal Group Plc (LON:DNL) is a clinical stage specialty pharmaceutical company focused on diseases of the endocrine system. It has two lead candidates – Infacort that..
Northland Capital Partners Head of Research Vadim Alexandre caught up with DirectorsTalk for an exclusive interview to discuss Evgen Pharma PLC (LON:EVG) Q1: Now we’re..
Hardman and Co Research Analyst Head of Research Tony Williams caught up with DirectorsTalk for an exclusive interview to discuss the housebuilding sector for 2016/2017: what..
Zeus Capital Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview to discuss Elegant Hotels Group PLC (LON:EHG) Q1: Mike, Elegant..
Headlam Group plc (LON:HEAD) saw strong trading in the last eight weeks of the year lead to further upgrades to forecasts, this follows the upgrades put..
Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today provides an update on trading for the six months ended 31..
Sirius Minerals Plc (LON:SXX) provides today an update on the future reporting of updates for its North Yorkshire polyhalite project following the successful completion of its..
UK Oil & Gas Investments PLC (LON:UKOG) announced today that UKOG Solent Limited, a 100%-owned subsidiary, has been advised that the Oil and Gas Authority has..
FairFX Group Plc (LON:FFX), the low cost multicurrency payments service, has today announced that it has agreed to acquire the entire issued ordinary share capital of..
Arria NLG plc (LON:NLG), a leader in Artificial Intelligence and Natural Language Generation, has today provided the following updates ahead of the cancellation of the Company’s..
